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Background: Integrity of functional brain networks is closely associated with maintained
cognitive performance at old age. Consistently, both carrier status of Apolipoprotein E
ε4 allele (APOE4), and age-related aggregation of Alzheimer’s disease (AD) pathology
result in altered brain network connectivity. The posterior cingulate and precuneus (PCP)
is a node of particular interest due to its role in crucial memory processes. Moreover,
the PCP is subject to the early aggregation of AD pathology. The current study aimed
at characterizing brain network properties associated with unimpaired cognition in old
aged adults. To determine the effects of age-related brain change and genetic risk
for AD, pathological proteins β-amyloid and tau were measured by Positron-emission
tomography (PET), PCP connectivity as a proxy of cognitive network integrity, and
genetic risk by APOE4 carrier status.
Methods: Fifty-seven cognitively unimpaired old-aged adults (MMSE = 29.20 ± 1.11;
73± 8.32 years) were administered 11C Pittsburgh Compound B and 18F Flutemetamol
PET for assessing β-amyloid, and 18F AV-1451 PET for tau. Individual functional
connectivity seed maps of the PCP were obtained by resting-state multiband BOLD
functional MRI at 3-Tesla for increased temporal resolution. Voxelwise correlations
between functional connectivity, β-amyloid- and tau-PET were explored by Biological
Parametric Mapping (BPM).
Results: Local β-amyloid was associated with increased connectivity in frontal and
parietal regions of the brain. Tau was linked to increased connectivity in more spatially
distributed clusters in frontal, parietal, occipital, temporal, and cerebellar regions. A
positive interaction was observable for APOE4 carrier status and functional connectivity
with brain regions characterized by increased local β-amyloid and tau tracer retention.
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Conclusions: Our data suggest an association between spatially differing connectivity
systems and local β-amyloid, and tau aggregates in cognitively normal, old-aged
adults, which is moderated by APOE4. Additional longitudinal studies may determine
protective connectivity patterns associated with healthy aging trajectories of
AD-pathology aggregation.
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BACKGROUND
Aggregation of beta-amyloid (β-amyloid) and
hyperphosphorylated tau are hallmarks of brain pathology
associated with Alzheimer’s Disease (AD). The age-related
accumulation of both proteins precedes disease onset by
decades (Price and Morris, 1999; Bateman et al., 2012). Recently
published data indicate a sequential association between brain
β-amyloid accumulation, subsequent tau change and resulting
cognitive decline (Hanseeuw et al., 2019). However, the precise
impact of β-amyloid and pathological tau on brain functionality
is not yet completely understood. Several studies demonstrated
the validity of positron-emission-tomography (PET) tracers
for inferring the relationship between AD-pathology burden,
and risk for severe cognitive impairment at old age (Klunk,
2011; Villemagne et al., 2011; Vos et al., 2013). Distinct
effects on brain network connectivity have been shown for
both β-amyloid and pathological tau burden (Hansson et al.,
2017; Hoenig et al., 2018; Korthauer et al., 2018; Franzmeier
et al., 2019; Hodgetts et al., 2019). Functional connectivity
changes within the ‘‘default mode network’’ (DMN) relate
to AD-pathology and precede the manifestation of cognitive
disorder by years (Sorg et al., 2007; Sperling et al., 2009; Wang
et al., 2013; Sorg and Grothe, 2015). Moreover, large clinical
studies demonstrate an association between AD-pathology
and brain functionality in non-demented old-aged adults, as
reflected by functional network integrity (Jack et al., 2019; Maass
et al., 2019; Ossenkoppele et al., 2019). This may be consistent
with functional network change in other neurodegenerative
diseases (Rektorova et al., 2012; Ross et al., 2014;
Kronenbuerger et al., 2019).
Despite the consensus in the literature that AD-pathology
is related to a breakdown in functional brain networks, its
associations with functional connectivity are tenuous. The
relationship between β-amyloid and decreased connectivity,
mainly in the DMN, is well established for clinically manifest AD
(Hedden et al., 2009; Sheline et al., 2010; Chhatwal et al., 2013;
Wang et al., 2013). However, during aging and in the absence
of cognitive disorder, both increased functional connectivity
(Mormino et al., 2011; Lim et al., 2014), but also decreased
network connectivity (Wang et al., 2013) has been observed to
be associated with AD-pathology when assessing total β-amyloid
load, and tau burden.
The posterior cingulate and precuneus (PCP) represents
a central node of the DMN needed for memory processing
(Sperling et al., 2009; Cieri and Esposito, 2018). β-amyloid
load affects the functionality of the PCP in old aged adults
with, and without cognitive impairment (Unschuld et al.,
2012; Schreiner et al., 2016; Grothe et al., 2017; Quevenco
et al., 2017, 2019). The Apolipoprotein E ε4 allele (APOE4)
is the strongest known genetic risk factor for late-onset AD
(Corder et al., 1993; Strittmatter et al., 1993; Beffert and
Poirier, 1996). In the general population, APOE4 carrier status
is associated with an increased risk for the presence of
AD-pathology (Schipper, 2011; Verghese et al., 2011; Liu et al.,
2013; Jack et al., 2019; Yamazaki et al., 2019). Consistently,
brain network alterations involving the PCP are pronounced
in carriers of the APOE4 genotype (Sperling et al., 2009;
De Vogelaere et al., 2012).
PET using tracers 18F-Flutemetamol and Pittsburgh
Compound B (PiB) by now is a well-established neuroimaging
technique for measuring individual β-amyloid plaque burden
(Vandenberghe et al., 2010; Klunk, 2011; Frisoni and Blennow,
2013). Moreover, PET tau tracers such as 18F AV-1451 have
enabled in vivo assessment of pathological, hyperphosphorylated
tau burden in humans (Schöll et al., 2017; Mainta et al., 2018;
Villemagne et al., 2018). These advances in PET technologies
allow for investigating the relationship of β-amyloid and tau,
whose interactions are considered to significantly contribute
to disease progression and functional decline (Selkoe and
Hardy, 2016; Tosun et al., 2017; Kametani and Hasegawa,
2018) Spatial distribution patterns of both proteins diverge
substantially, with β-amyloid accumulation beginning in the
neocortex and progressing towards subcortical structures
(Braak and Braak, 1991a), whereas tau accumulation begins
in the brainstem and transentorhinal regions and spreads
towards neocortical structures as the disease progresses (Braak
and Braak, 1991b). Considering these earlier reports, we
hypothesized that PCP functional connectivity in cognitively
normal old-aged adults might reflect the interplay between
β-amyloid and tau pathology on a local level. Moreover, we
hypothesized, that such effects should be more pronounced
in APOE4 carriers. To test these hypotheses, the relationship
between local β-amyloid, local tau and PCP connectivity
was investigated on a voxel-level. We used the software
biological parametric mapping (BPM; Casanova et al., 2007)
for generating subject-specific PET tracer retention patterns
and beta-maps (Whitfield-Gabrieli and Nieto-Castanon,
2012) as a measure of individual connectivity patterns
(Biswal et al., 1995), associated with AD pathology. High
temporal resolution of connectivity data was achieved by
using multiband functional MRI (fMRI) for the simultaneous
acquisition of multiple slices (Feinberg and Setsompop, 2013;
Preibisch et al., 2015).
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MATERIALS AND METHODS
Study Population
For the current study, 57 old-aged cognitively unimpaired
(mean MMSE = 29.20 ± 1.11), and medically healthy
adults (mean age = 73 ± 8.32 years) were included from
an on-going neuroimaging study at our institute, using
study procedures reported earlier (van Bergen et al., 2018a;
Vandenberghe et al., 2010). Written informed consent was
obtained from all participants before inclusion in the study.
Study procedures were carried out in accordance with the Good
Clinical Practice (GCP) guidelines issued by the local ethics
authority (Kantonale Ethikkommision Zürich1), and with the
Human Research Act of Switzerland and the declaration of
Helsinki (World_Medical_Association, 1991).
Inclusion criteria were age above 50 years, pre-existing PET
information on cerebral amyloid deposition, German language
proficiency and capacity to consent to study procedures.
Exclusion criteria were: significant medication or drug abuse
that might have possible effects on cognition, a history of
severe allergic reaction or known allergy against components
of 11C-PiB, 18-Flutemetamol, AV-1451, general MRI exclusion
criteria, MRI scans with evidence of infection or infarction and
severe atrophy, clinically relevant changes in red blood cell
count, serious medical or neuropsychiatric illness and significant
exposure to radiation.
Flutemetamol and PiB-PET for Estimation
of β-amyloid Load
Individual measures of local β-amyloid burden were determined
by quantification of standardized uptake values of either
18F-Flutemetamol (34 participants) or 11C-Pittsburgh
Compound B (11C-PiB, 23 participants). PET was performed
as reported in earlier studies of ours (Schreiner et al., 2014;
Steininger et al., 2014; van Bergen et al., 2018a). A General
Electric (GE) healthcare SIGNA PETMR was used for measuring
18F-Flutemetamol uptake, and a GE healthcare Discovery
scanner for 11C-PiB. Average and standard deviation (SD) maps
of all amyloid-PET SUVR are indicated in Supplementary
Figures S1, S2. For the former, an individual dose of
approximately 140 MBq of Flutemetamol was injected
into the cubital vein. Time-of-flight algorithms and the
required corrections were applied to reconstruct the PET
images. Late-frame values (85–105 min) were referenced to
the cerebellar gray matter (Vandenberghe et al., 2010) to
obtain 3D volumes of Flutemetamol retention as an estimate
β-amyloid load using standardized uptake value ratios (SUVR;
matrix = 256 × 256 × 89, voxel size = 1.2 × 1.2 × 2.78 mm3).
For the PiB protocol, approximately 350 MBq were administered
intravenously and late-frame values (50–70 min) were used
to obtain mean PiB uptake in all cortical VOIs and cerebellar
regions using a volume-weighted averaging procedure (Gietl
et al., 2015). Identical to the Flutemetamol protocol, these were
normalized and referenced to the cerebellar gray matter to obtain
SUVRs as estimates of the β-amyloid load.
1www.kek.zh.ch
AV1451-PET for the Estimation of Tau Load
The current study also included measures of tau load, by
assessing local retention of 18F-AV1451 using an established
PET procedure (Chien et al., 2013). A GE healthcare SIGNA
PETMR was used for measuring 18F-AV1451 uptake.
Average and SD maps of all tau-PET SUVR are indicated in
Supplementary Figures S3, S4. In our study, an individual dose
of approximately 200 MBq of 18F-AV1451 was administered
into the cubital vein. Similar to the β-amyloid procedure, time-
of-flight algorithms with the necessary corrections were applied
to construct the tau-PET images based on regional uptake
values. For analysis, 8 × 5 min frames were acquired. These were
summed to late-frame values (80–120 min) and referenced to the
cerebellar gray matter for generation of SUVRs.
MRI Acquisition
MR-Images were acquired on a 3-Tesla GE Discovery 750w MR
whole-body scanner (GEMedical Systems,Milwaukee,WI, USA)
equipped with a 32 Channel head coil array. A 3D T1-weighted
(IR-SPGR) sequence (TI = 600 ms, TE = minimum, voxel
size = 1 × 1 × 1 mm3, FOV = 256 × 256 × 256 mm3,
flip angle = 8◦, scan time = 5:49 min) was used to obtain
structural images for anatomical referencing and automated
image segmentation at the same visit the AV1451-PET was
performed for tau. The average time betweenMRI and β-amyloid
PETwas 1,138 days, with aminimum of 49 days, and amaximum
of 2,414 days.
Resting-state BOLD fMRI images were acquired using a
2D Gradient Echo Mux Multiband sequence (TR = 2,000 ms,
TE = 30 ms, flip angle = 70◦, slice thickness = 2.4 mm, number of
slices = 22, number of MUXed slices (1–8) = 3, Autocalibrating
Reconstruction for Cartesian imaging (ARC) acceleration
factor = 2, ARC enabling = 1, scan time = 8:32 min) to
obtain individual beta maps, indicating functional connectedness
of each voxel to the PCP based on BOLD synchronicity
(Biswal et al., 1995; Whitfield-Gabrieli and Nieto-Castanon,
2012). Average and SD maps PCC connectivity are indicated in
Supplementary Figures S5, S6.
Pre-processing of Functional Images and
Obtaining PCP Seed Maps
Functional images were spatially preprocessed using an in-house
script implementing functions from the SPM12 toolbox2
with MATLAB 2016a (Mathworks, Natick, MA, USA). The
following spatial preprocessing measures were covered in
the script: (1) Functional image time-series were realigned
using a 6-parameter rigid-body transformation for each image.
(2) Anatomical (T1) scans were coregistered to the mean
functional image. (3) Structural T1 images were segmented using
SPM12’s Segment function in order to obtain tissue probability
maps to warp the functional images into normalized MNI space.
(4) Functional and structural images were normalized by using
the forward deformations obtained in the previous step to
warp the images from native into MNI space. (5) Normalized
functional images were then smoothed with an 8 mm FWHM
2http://www.fil.ion.ucl.ac.uk/spm/software/spm12
Frontiers in Aging Neuroscience | www.frontiersin.org 3 March 2020 | Volume 12 | Article 46
Quevenco et al. Brain Connectivity, Aβ, Tau, APOE4
Gaussian kernel. Slice-time correction is not a necessity with
multiband images due to the low TR, which reduces temporal
differences between slices. In addition, as multiband acquires
a high number of slices, the slight movement could have
corrections done for the wrong slice. In order to avoid this
complication, this step was omitted from spatial preprocessing.
Normalized and smoothed functional and normalized T1 images
were processed using the CONN v12 toolbox (Whitfield-
Gabrieli and Nieto-Castanon, 2012). This toolbox uses the
CompCor denoising method procedure, which regresses out
nuisance regressors without including the global signal. After the
denoising step, PCP seed maps were obtained using the CONN
toolbox by calculating the correlation between the PCP and other
regions of the brain.
Biological Parametric Mapping (BPM) for
Voxel-Level Analysis
PET images were, based on their co-registered T1 image, aligned
to the TAU PET/MR T1 image using the PMOD software,
Version 3.8 (PMOD Technologies Limited, Zurich, Switzerland).
T1MRI images were normalized toMNI space andmatrices were
applied to the PET images, which were then scaled by cerebellum
gray matter values derived from an intersected Hammers atlas
derived gray matter region, which fit all normalized PET images.
These were then smoothed with a 5 mm FWHM Gaussian
kernel. Preprocessing of the functional images for BPM analysis
required realignment, coregistration, segmentation and warping
into MNI space and finally smoothed with an 8 mm FWHM
Gaussian kernel using in-house scripts running on SPM122
with MATLAB 2016a (Mathworks, Natick, MA, USA). The
smoothed and normalized functional images were processed
using the CONN v.12 toolbox (Whitfield-Gabrieli and Nieto-
Castanon, 2012). Individual Fisher r-to-z transformed beta PCP
seed connectivity maps were calculated for each participant. A
second level t-test against zero was applied on the data and
multiple test correction was performed at the voxel level, using
FDR (p-FDR corrected, q < 0.05 for p-uncorrected = 0.001,
Figure 1). To limit the analysis to the gray matter, images
were masked using a multi-atlas matching approach (van Bergen
et al., 2018b). Regression analysis of normalized and smoothed
PET and fMRI images was performed by administering BPM3
(Casanova et al., 2007; Yang et al., 2011), a toolbox useful
for exploring multimodal voxel-level correlations using the
General Linear Model (GLM), running under Matlab 2010a
and SPM54. The common spatial resolution of the images
used in the analysis was determined by the spatial modality
of PET (the lowest resolution) of approximately 3 mm. BPM
was used to investigate regression models for investigating
the relationship between local β-amyloid PET, tau-PET and
DMN connectivity, as measured by beta maps, with a BPM
cluster threshold set at 100 voxels. Additionally, the potential




FIGURE 1 | Posterior cingulate and precuneus (PCP) connectivity seed map
of sample population. (A) Connectivity map of the whole sample
(p-FDR < 0.05), using the PCP as a seed, projected on a 3D brain. (B) The




All participants underwent a battery of neuropsychological tests
including the Mini-Mental State Exam (MMSE), the Boston
Naming, Trail-Making and the VLMT Delayed Recall test.
Mini-Mental State (MMSE) scores were within the normal range
(mean MMSE = 29.20 ± 1.11), and the other neuropsychological
tests indicated consistently high performance of the studied
population in the investigated domains (Supplementary Table
S1). Moreover, genotyping identified 11 APOE4 carriers within
the 57 study participants (19.3% of the population).
Local β-amyloid and Tau Deposits Are
Associated With Locally Increased
Functional Connectivity
By applying voxel-wise regression, eight positively associated
clusters with a size of at least 100 voxels (Total voxels = 2,030,
T > 2.3, p < 0.05) could be identified, indicating relationships
between local β-amyloid load and increased PCP connectivity.
Clusters were mainly located in the frontal and parietal lobe
(Figure 2A), including the middle frontal gyrus, the anterior
orbital gyrus (right), the medial orbital gyrus (right), the lateral
orbital gyrus (right), the left precentral gyrus, the inferior lateral
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FIGURE 2 | Regions that show correlations between local β-amyloid, local
tau, and increased functional connectivity. (A) Axial, coronal, and sagittal
slices and a 3D render of the T-map (p < 0.05, extent threshold = 100 voxels)
illustrating the regions with correlations between local β-amyloid and
increased connectivity (blue). (B) Axial, coronal, and sagittal slices and a 3D
render of the T-map (p < 0.05, extent threshold = 100) illustrating the regions
with correlations between local tau load (green) and increased
functional connectivity.
remainder of the parietal lobe (right) and other regions such
as the left anterior temporal lobe (medial part) and the left
cerebellum. No significant association between local β-amyloid
burden and decreased PCP connectivity could be observed.
Also, when applying voxel-wise regression, no significant
relationship could be observed between age and gender, and
PCP connectivity.
For local tau associated PCP connectivity changes, the voxel-
based analysis identified 14 positively associated clusters with a
minimum size of 100 voxels (Total voxels = 5,662, T > 2.26,
p < 0.05) widely distributed across the brain (Figure 2B).
Regions primarily involved were thalamus, superior frontal
gyrus, middle frontal gyrus, the inferolateral remainder of the
parietal lobe (right), superior parietal gyrus, the lateral remainder
of the occipital lobe, posterior temporal lobe and middle and
inferior temporal gyrus. Smaller clusters included the cingulate
gyrus and the right cerebellum.
There were small regions of overlap (257 voxels) between local
β-amyloid associated connectivity and tau-related connectivity
(Figure 3), representing ca. 12.66% of voxels included in
the β-amyloid PCP connectivity map and 4.54% of the tau
PCP connectivity map. The overlap between β-amyloid and
tau-related connectivity was observable in particular for the left
and right cerebellum, superior frontal gyrus and the inferolateral
remainder of the parietal lobe (right).
APOE4 Carrier Status Moderates the
Association Between β-amyloid and Tau
Load With Functional Connectivity
APOE4 carrier status was included in the regression model as a
non-imaging covariate and was found to have positive moderator
effects on both β-amyloid and tau-related functional connectivity
properties (Figure 4). APOE4 carrier status and local β-amyloid
load were associated with increased PCP connectivity in
14 clusters of at least 100 voxels (Total voxels = 3,666, T > 2.80,
FIGURE 3 | The minor regional overlap between local β-amyloid and
increased PCP connectivity and local tau and increased PCP connectivity.
Axial, coronal, and sagittal slices showing the small regional overlap of
regions that are associated with local β-amyloid and increased PCP
connectivity (p < 0.05, extent threshold = 100 voxels), and local tau-load and
increased PCP connectivity (p < 0.05, extent threshold = 100 voxels).
FIGURE 4 | Regions with increased connectivity associated with local
β-amyloid, local tau, and Apolipoprotein E ε4 allele (APOE4) carrier status.
(A) Axial, coronal, and sagittal slices and a 3D view of the biological
parametric mapping (BPM) T-map (p < 0.05, extent threshold = 100)
illustrating regions with associations between local β-amyloid, increased
functional connectivity, moderated by APOE4 carrier status (blue). (B) Axial,
coronal, and sagittal slices and a 3D view of the BPM T-map (p < 0.05,
extent threshold = 100) illustrating regions that showed associations between
local tau, increased connectivity, moderated by APOE4 carrier status (green).
p< 0.05). In contrast to the regressionmodel with just β-amyloid
and the Fisher r-to-z beta maps, which found regions with the
strongest associations in the frontal lobe, APOE4 status and
local β-amyloid were associated with more widely distributed
PCP connectivity changes primarily in the temporal and frontal
lobe (Figure 5A). These included the left anterior temporal
lobe (medial and lateral part), posterior temporal lobe, right
middle and inferior temporal gyrus, left middle frontal gyrus, left
precentral gyrus, right medial orbital gyrus, and the right anterior
orbital gyrus. Other regions included in the clusters were the
right thalamus, the inferolateral remainder of the parietal lobe
and the left lingual gyrus in the occipital lobe.
Local tau-tracer retention and APOE4 carrier status were
associated with increased PCP connectivity in 13 clusters
with at least 100 voxels in size (Total voxels = 7,045,
T > 2.5, p < 0.05). Similar to the findings from the
local tau and connectivity regression model, regions with
strong associations between increased connectivity, local tau,
and APOE4 carrier status were widely distributed across
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FIGURE 5 | Effects of APOE4 carrier status on regional associations
between increased connectivity with (A) local β-amyloid, and (B) local tau.
(A) Axial slices of regions with correlations between local β-amyloid and
increased connectivity (blue), and local β-amyloid, APOE4 carrier status and
increased PCP connectivity (orange). (B) Axial slices of regions associated
with local tau-load and the Fisher r-to-z transformed beta-maps (green), local
tau-load, APOE4 carrier status and increased PCP connectivity (orange).
the brain (Figure 5B). Primary regions were located in the
neocortex and also include other central structures, such as
the cerebellum, the thalamus and caudate nucleus. These
clusters enclosed brain regions within the right superior
frontal gyrus, middle frontal gyrus, superior parietal gyrus,
the lateral remainder of the occipital lobe, right middle and
inferior temporal gyrus, and posterior temporal lobe. Similarly
as with β-amyloid, no significant association between local
retention of the tau-tracer and decreased PCP connectivity could
be observed.
DISCUSSION
By applying a multimodal voxel-wise regression approach
to non-demented old-aged adults, we identified relationships
between local β-amyloid and tau deposits with functional
connectivity changes of the PCP. While local aggregation of
both proteins was associated with distinct patterns of functional
hyperconnectivity, the regional overlap was small. As we did find
a positive moderator effect of APOE4 for both β-amyloid and tau
related connectivity, we assume potential relevance for risk and
progression of AD.
The majority of studies in the past have found decreased
functional connectivity in the presence of AD (Sheline et al.,
2010; Ouchi and Kikuchi, 2012; Song et al., 2013) and β-amyloid
deposition (Sperling et al., 2010), particularly affecting the DMN
and even reduction of connectivity in specific DMN nodes, such
as the posterior cingulate (Weiler et al., 2014). There is however
a handful of contradicting findings that observed increased
connectivity and postulated that these changes may be exemplary
of early-stage compensatory mechanisms in reaction to brain
pathology (Mormino et al., 2011; Lim et al., 2014).
Though the reduction in connectivity is a prominent finding
in the literature, our results coincide with a longitudinal
PET connectivity study (Jack et al., 2013) and a recent β-
amyloid and tau study (Schultz et al., 2017), that suggests
that along the AD spectrum there are phases of hyper-
and hypoconnectivity, with the former preceding the latter.
Moreover, our findings are consistent with recent data
on functional alterations associated with the presence of
AD-pathology in non-demented old-aged adults (Jack et al.,
2019; Maass et al., 2019; Ossenkoppele et al., 2019). Considering
that the here investigated study population still had a low β-
amyloid burden (Aβ−) and was cognitively relatively healthy,
the observed increase in PCP connectivity may reflect the
presence of pathological impairment prior to significant β-
amyloid aggregation. The observed β-amyloid associated PCP
connectivity was focal and significant clusters were located in
the frontal and temporal lobe. Tau, however, was associated
with increased activity in a wider distribution of regions
across the brain. Only limited spatial overlap between PCP
connectivity networks affected by β-amyloid and tau were
observable. Overlap was present in the superior frontal
gyrus, the cerebellum and the inferolateral remainder of the
parietal lobe. While our data needs to be interpreted with
caution due to the low level of PET tracer retention in an
Aβ− population, possible off-target tau signal (Baker et al.,
2019) and the possibility of slightly different attenuation
correction due to the use of different PET scanners, our
data nevertheless may accord with recent fMRI studies
that suggest distinct PCP functional connectivity networks
associated with β-amyloid and tau (Sepulcre et al., 2017;
Franzmeier et al., 2019).
Interestingly, we found more clusters to be associated with
local β-amyloid load and APOE4 carrier status than β-amyloid
alone and these clusters are no longer primarily in the frontal
lobe but cover many parts of the neocortex as well as other
central structures, such as the cerebellum, thalamus and the
caudate nucleus. While the addition of the genetic AD risk
factor to the regression model better explains PCP associated
increased connectivity in our data, this may be consistent with
earlier reports on APOE4 associated connectivity changes in
non-demented populations (Westlye et al., 2011; Wang et al.,
2015; Hodgetts et al., 2019). However, this relationship was less
prominent for local tau and PCP connectivity. Although adding
APOE4 carrier status as an independent covariate did show some
regions that were not affected with only tau alone, APOE4 effects
on tau appeared less widespread. While our findings might
support earlier reports on an association between APOE4 and
tauopathy (Beffert and Poirier, 1996; Tiraboschi et al., 2004; Shi
et al., 2017), in our study APOE4 moderated the relationship
between local tau and functional connectivity to a lesser degree
than β-amyloid.
Nonetheless, this observation could be a reflection
of the relatively healthy status of our population, where
neurodegenerative brain damage, indicated by increased tau,
may still be very limited, resulting in low power for the detection
of interactive effects between tau, APOE4 and functional
connectivity. This may accord with the amyloid cascade
hypothesis, which postulates that β-amyloid dysregulation
precedes tau related neurodegeneration in preclinical stages
of AD (Hardy and Selkoe, 2002). Furthermore, this study
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only finds relationships between β-amyloid and tau with
increased PCP connectivity. Our finding of distinct functional
impacts of β-amyloid and tau might be consistent with the
notion of pathogenic synergism of protein aggregates in
aging and neurodegenerative disease (Nelson et al., 2012).
However, our findings may also reflect other non-AD related
tauopathy, which might concur with very early stages of
potential β-amyloid pathology in the studied population.
Possible implications for therapeutic intervention strategies
against age-related cognitive decline have been reviewed recently
(Pini et al., 2018).
For the current study multiband fMRI was used, allowing
for increased temporal resolution of resting-state data (Feinberg
and Setsompop, 2013; Preibisch et al., 2015) while maintaining
reproducibility of results with conventional EPI based fMRI
protocols (Smitha et al., 2018). The increase in temporal
resolution made possible by multiband fMRI has been suggested
to allow for novel insights in brain network dynamics
(Preibisch et al., 2015).
However, the cross-sectional nature and small sample size
is a limitation of our study. Furthermore, due to the small
sample size, further stratification of the studied population
by AD-relevant properties is not compatible with the chosen
statistical analysis strategy. While we did not find effects of
gender and age, these might be present in a larger study
population, particularly if a wider age range is included. Also,
the specific investigation of APOE4 carriers, and also limiting
the analysis to individuals with high cerebral β-amyloid (Aβ+
vs. Aβ−), and effects associated with tau progression beyond
the entorhinal cortex, may provide additional insights on AD
pathology (Braak and Braak, 1991b; Thal et al., 2002). While it
is difficult to conclude whether our findings reflect pathological
stages associated with either β-amyloid or tau, recent data suggest
a sequential association of pathological change in AD (Hanseeuw
et al., 2019). Prospective, longitudinal studies may include
trajectories of gray matter integrity, as demonstrated recently
for estimating neural tissue disintegration (Koini et al., 2018).
Moreover, as we investigated a relatively healthy population,
information on a relationship between connectivity-properties
and structural change of vulnerable brain regions is limited.
At present, 18F AV-1451 has become a popular choice for
in vivo tau imaging (Villemagne et al., 2018; Mattsson et al.,
2019; Smith et al., 2019). However, AV-1451 off-target binding
unrelated to tau is a frequent finding particularly at low tracer
retention, as observed in our study. Here, AV-1451 off-target
signal may reflect iron deposition, neuromelanin, or vascular
factors (Lockhart et al., 2017). This particularly affects brain
regions such as the thalamus, putamen, superior cerebellar gray,
choroid plexus, but also meninges and skull, posing challenges
when studying early tau accumulation, as done in the current
study (Baker et al., 2019). Functional coupling between the
PCP and the PCC is well known, and our finding of an
association with local β-amyloid may accord with earlier reports
on altered functional brain changes during aging (Steininger
et al., 2014; Li et al., 2017; Liu et al., 2017; Luo et al., 2019).
However, considering that no significant cerebellar β-amyloid
accumulation is to be expected in cognitively healthy individuals
(Thal et al., 2002), also this finding needs further replication,
and for now, needs to be interpreted with caution. Another
limitation is the fact that there was significant temporal delay
between β-amyloid PET and MRI, while tau PET and MRI took
place at once. This difference needs to be taken into account
when interpreting our findings on connectivity effects associated
with β-amyloid vs. tau. However, β-amyloid effects may manifest
in the long term, considering that aggregation of β-amyloid
has been estimated to take about 19 years from β-amyloid
positivity-threshold to mean values observed in AD dementia
(Roberts et al., 2017).
Moreover, although the PCP is considered to play a central
role in various cognitive processes associated with the DMN
(Choo et al., 2010; Teipel et al., 2015; Quevenco et al., 2017;
Cieri and Esposito, 2018), PCP seed map-related effects observed
in this study may nevertheless primarily reflect PCP specific
pathology than general alterations of the DMN. Follow-up
studies using whole-brain connectivity approaches both at rest
and during cognitive tasks may thus expand findings of the
current study to investigate the DMN and also other brain
networks in the context of AD-risk. Here, the advent of novel
blood-based biomarkers might help to further characterize
processes resulting in impaired brain functionality in preclinical
AD (Bacioglu et al., 2016; Mattsson et al., 2017; Zetterberg and
Blennow, 2018).
In conclusion, our findings are consistent with recently
published studies that describe phases of PCP hyperconnectivity
during the early stages of age-related β-amyloid and tau-related
aggregation (Sepulcre et al., 2017). Considering the central role
of the PCP for DMN connectivity, our study suggests that
APOE4 carrier status, aggregation of β-amyloid and tau closely
interact regarding their effects on DMN connectivity. Additional
studies are needed to clarify connectivity in the context of the
sequential progression of AD pathology (Hanseeuw et al., 2019),
early functional change (McLaren et al., 2012), and potential
opportunities for therapeutic intervention (Pini et al., 2018). The
fact that these effects are observable before the manifestation
of dementia, but still are related to APOE4 carrier status, may
indicate relevance for the progression of early AD-pathology
(Haller et al., 2019). Thus, further longitudinal studies are needed
to investigate the temporal sequence of the observed changes, and
whether they are associated with accelerated disease progression.
Such studies may also inform on functional connectivity in
a context of resilience against the aging-related accumulation
of AD pathology. Possibly protective effects of functional
connectivity patterns may allow for compensating emerging
brain pathology during aging, allowing for preserved cognition.
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FIGURE S1 | Amyloid average over all PET scans performed (18F Flutemetamol
and 11C PiB). Scaled from 0 to 2.8 SUVR.
FIGURE S2 | Amyloid standard deviation (SD) over all PET scans performed
(18F Flutemetamol and 11C PiB). Scaled from 0 to 0.8 SUVR SD.
FIGURE S3 | Tau average over all PET scans performed (18F AV1451). Scaled
from 1.0 to 2.0 SUVR.
FIGURE S4 | Tau SD over all PET scans performed (18F AV1451). Scaled from 0
to 0.6 SUVR SD.
FIGURE S5 | Beta-maps average, scaled from 0 to 1.0.
FIGURE S6 | Beta-maps SD, scaled from 0 to 0.3.
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